Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer

Background: Previous prospective studies have shown that eribulin improves the survival in patients with metastatic breast cancer (MBC). However, the optimal timing of its administration to achieve the longest extended survival and the efficacy of using eribulin monotherapy as earlier-line chemother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Cancer
Main Authors: Shingaki, Sumito, Kogawa, Takahiro, Shimokawa, Mototsugu, Harano, Kenichi, Naito, Yoichi, Kusuhara, Shota, Fujimoto, Yumi, Matsubara, Nobuaki, Hosono, Ako, Mukai, Hirofumi, Onishi, Tatsuya, Hojo, Takashi, Mukohara, Toru
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196254/
https://ncbi.nlm.nih.gov/pubmed/32368292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.37670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados